Want to track R0V and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
R0V trading today higher at €18.48, an increase of 0% from yesterday's close, completing a monthly decrease of -17.87% or €4.02. Over the past 12 months, R0V stock lost -17.87%.
R0V is not paying dividends to its shareholders.
Revenio Group Oyj has completed 1 stock splits, with the recent split occurring on Mar 20, 2020.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on XMUN (EUR).
Revenio Group Oyj (R0V) FAQ
What is the stock price today?
The current price is €18.48.
On which exchange is it traded?
Revenio Group Oyj is listed on XMUN.
What is its stock symbol?
The ticker symbol is R0V.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 1.92%.
What is its market cap?
As of today, the market cap is 556M.
Has Revenio Group Oyj ever had a stock split?
Revenio Group Oyj had 1 splits and the recent split was on Mar 20, 2020.
Revenio Group Oyj Profile
| Health Care Providers & Services Industry | Healthcare Sector | Mr. Jouni Toijala B.Sc., M.B.A. CEO | XMUN Exchange | - ISIN |
| US Country | 247 Employees | - Last Dividend | 20 Mar 2020 Last Split | - IPO Date |
Overview
Revenio Group Oyj, established in 2001 and headquartered in Vantaa, Finland, operates internationally, specialising in ophthalmological devices and software solutions. The company targets a range of eye conditions including glaucoma, macular degeneration, and diabetic retinopathy, offering its solutions to multiple markets such as Finland, the rest of Europe, North America, and beyond. Through its innovative product lineup and software platforms, Revenio Group Oyj addresses the critical needs of healthcare professionals and patients in the ophthalmology sector.
Products and Services
- iCare IC100 and IC200 tonometers: Essential devices designed for the precise measurement of intraocular pressure (IOP), offering a non-invasive solution critical in the diagnosis and management of glaucoma.
- iCare HOME: A revolutionary device enabling patients to measure their eye pressure independently, facilitating regular monitoring outside clinical settings and enhancing patient engagement in their healthcare.
- iCare TONOVET: This device is specifically tailored for use on animal patients, utilized by general veterinary practitioners, veterinary ophthalmologists, and other veterinary medical personnel for accurate IOP measurement, making it a versatile tool in veterinary ophthalmology.
- iCare EIDON AF: A state-of-the-art device offering confocal retinal imaging, iCare EIDON AF provides detailed and high-quality images, essential for the accurate diagnosis and monitoring of various retinal conditions.
- DRSplus: Specialized in pupil imaging, the DRSplus facilitates comprehensive examinations of the pupil, enabling healthcare professionals to conduct thorough assessments and diagnosis.
- iCare COMPASS: An advanced device combining fundus perimetry with true-color confocal retinal images, iCare COMPASS offers a holistic view of the eye health, supporting accurate diagnoses and tailored treatment approaches for patients.
- Oculo: A cutting-edge eye care software platform that merges clinical communication, telehealth, and remote patient monitoring with data analytics, Oculo stands at the forefront of digital healthcare solutions in ophthalmology, fostering improved patient outcomes and streamlined healthcare provider workflows.
Contact Information
Address: Äyritie 22, Vantaa, Finland, 01510
Phone: 358 9 8775 1150
Website: https://www.reveniogroup.fi
